Background: Sepsis is a significant cause of morbidity and mortality worldwide despite advanced critical life-support. Septic shock and multiorgan dysfunction is the terminal stage in critically ill patients leading to perfusion abnormalities, lactic acidosis, oliguria and altered mental status creating a rapid downhill course and mortality. Sepsis ensues through stages of exaggerated immune response including systemic inflammatory response syndrome, in the backdrop of infectious stimuli.
INTRODUCTION
Sepsis is a major cause of morbidity and mortality worldwide despite advanced critical life-support. It is the 11 th leading cause of death overall with attributable mortality to sepsis and severe sepsis being 30 to 50% and 50 to 60%. Following a non-infectious or infectious insult, there is a preliminary systemic response which becomes overwhelming leading to systemic inflammatory response syndrome. When the compensatory anti-inflammatory reaction fails, it leads to immunomodulatory failure, severe sepsis, septic shock, and multiorgan dysfunction. Sepsis ensues prolonged hospital stay and aggressive exposure to a cocktail of antimicrobials thereby increasing healthcare costs and furthering antimicrobial resistance. [1] [2] [3] Septic shock and multiorgan dysfunction is the terminal stage in critically ill patients leading to perfusion abnormalities, lactic acidosis, oliguria and altered mental status creating a rapid downhill course and mortality. Sepsis ensues through stages of exaggerated immune response including systemic inflammatory response syndrome, in the backdrop of infectious stimuli. Polymicrobial septic shock with multiorgan dysfunction in an otherwise healthy immunocompetent patient is being presented.
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CASE REPORT
A 46-year-old woman with no known history of chronic disease, presented with mild to moderate grade intermittent fever with chills, dry cough without hemoptysis, sore throat, malaise and generalized body aches of two weeks duration. Initial outpatient workup for tropical fever comprising malaria, typhoid, dengue, chikungunya was negative. Subsequently, the patient presented with a febrile toxic look, breathlessness at rest, tachycardia 134/ min, normal blood pressure with no postural variation and hypoxemia at room temperature requiring oxygen inhalation and was promptly admitted to acute care. Examination revealed posterior pharyngeal wall congestion with mucus plugs; bilateral harsh vesicular breath CASE REPORT sounds with fine crackles without associated wheeze or chest pain. She was initiated on parenteral co-amoxiclav, amikacin, and clarithromycin while on oxygen support, bronchodilators through nebulization and supportive therapy. During her illness, her hemoglobin was 8.5 mg/dL, leucocytes 12800/cu mm with neutrophils 86% and lymphocytes 07%, platelets 77,000/cu mm, normal peripheral blood smear without atypical lymphocytes or toxic granules or malarial parasite. D-dimer was 9 mcg/ mL (normal < 0.5 mcg/mL) with normal fibrinogen and co-agulogram. Renal function tests, serum electrolytes, and liver function tests were within normal limits except lactate dehydrogenase which was 555 IU/mL. Urine was acidic with increased sugar, protein and leucocytes. Arterial blood gas, pH and oxygen saturation was maintained. Two-dimensional echocardiography revealed normal cardiac function with an ejection fraction of 65%, normal valves, and pericardium. Ultrasonography abdomen revealed mild splenomegaly with minimal left-sided pleural effusion.
She deteriorated 12-hours post admission rapidly with worsening of breathlessness, hypoxemia on mask ventilation, impending type-1 respiratory failure, and hypotension. She was shifted to intensive care and initiated on mechanical ventilation and inotropes. Antimicrobials were changed to ticarcillin-clavulanate, teicoplanin, levofloxacin, artesunate, and oseltamivir along with methylprednisolone, central venous pressure guided fluids, stress ulcer prophylaxis, and lung protective ventilation. Influenza a seasonal, pandemic H1N1 and influenza B reverse transcriptase polymerase chain reaction, serology for epstein-barr virus (EBV), enterovirus and Hantavirus was negative. On 3rd day, she was detected to have myocardial dysfunction with secondary myocarditis with persistent sinus tachycardia for 48 hours, elevated natriuretic peptide, creatine-kinase muscle/brain and troponin-I, non-specific ST-T changes, biventricular dysfunction on echocardiography, left and right ventricular ejection fraction 40% each. On 4th day, she developed sudden bradycardia with refractory hypotension followed by an asystolic cardiac arrest for which she was resuscitated and continued on a ventilator and triple inotropic support while Glasgow Coma Scale (GCS)
along with serum procalcitonin 5 ng/mL was detected. She sustained cardiac arrest on 14th day from which she couldn't be revived.
An autopsy revealed anasarca, ascites, bilateral lung abscesses, multiple petechiae over the heart and left kidney, congested greasy hepatosplenomegaly, and intracerebral hemorrhage in right basal ganglia (Fig. 1) . Microscopically, pus from lung abscess showed Gram-negative bacilli. Congested and consolidated lungs, myocardial hypertrophy with a mononuclear interstitial infiltrate, macrovesicular liver steatosis and early chronic passive congestion, congested and dilated splenic red pulp with attenuated white pulp and acute tubular necrosis were observed microscopically. Bacterial colonies in the tissue spaces of lungs and liver as well as cerebrospinal fluid grew Pseudomonas aeruginosa which showed similar antibiogram typing profile as ante-mortem Pseudomonas (Figs 2 to 4). 
DISCUSSION
Polymicrobial sepsis in this patient was evident from fever, tachypnoea, tachycardia, hypotension, PaO 2 /FiO 2 < 250, metabolic acidosis, azotemia, anemia, leucocytosis, thrombocytopenia, biventricular dysfunction requiring inotropic support and ventilator support. Polymicrobial sepsis with co-infective emerging bacterial and viral pathogens can cause severe disease which is worsened by healthcare-associated infections thereby obfuscating the clinical presentation and creating caveats to optimal diagnosis and treatment.
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Lipopolysaccharide, lipid A and endotoxin from Gram-negative pathogens, lipoteichoic acid from Grampositive pathogens, components from fungi, parasites and viruses stimulate. Toll-like receptor-mediated signaling leading to activation of NF-kb within monocytes. Proinflammatory cytokines, tumor necrosis factor-a (TNF-a) and interleukine-1 released in bloodstream lead to the production of toxic downstream mediators, including prostaglandins, leukotrienes, platelet-activating factor, and phospholipase A2. These cytokines damage the endothelium and facilitate production of adhesion molecules on endothelial cells and neutrophils. Neutrophilendothelial interaction releases endothelium damaging neutrophil components and nitric oxide which is a potent vasodilator. Interleukine-1 (IL-1) and TNF-a induce tissue factor expression on endothelium and monocytes leading to the production of thrombin resulting in fibrin clots in the microvasculature and impaired fibrinolysis due to the production of plasminogen activator inhibitor-1. Proinflammatory cytokines disrupt naturally occurring coagulatory and inflammatory mediators, activated protein C (APC) and antithrombin, leading to inhibition of factors Va and VIIIa, leukocyte adhesion and rolling, and neutrophil accumulation.
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CD4 lymphocytes initially assume a TH1 phenotype producing pro-inflammatory mediators including interferon gamma, TNF-a, and IL-2, and later convert to Th2 phenotype producing anti-inflammatory cytokines including IL-10, IL-4 and IL-13 under the influence of stress hormones such as catecholamines and corticosteroids. These cytokines dampen the immune response, deactivate monocytes promote apoptosis of gut lymphocytes in the gut leading to immunoparalysis. Cardiovascular compromise occurs due to TNF induced myocardial depression, vasodilation, and capillary leak.
There are caveats to the approach to polymicrobial sepsis on clinical and diagnostic fronts. 13 Biomarkers are heavily relied upon for diagnosis, prognosis, and initiation of antimicrobial therapy. Positive acute phase reactants such as C-reactive proteins (CRP), procalcitonin, fibrinogen, serum amyloid A, factor B and D, mannosebinding protein, von Willebrand factor, haptoglobulin, C1-C9 complement components, a-1 acid glycoprotein, a-1 antitrypsin and properdin are increased, while albumin, transferring and antithrombin are reduced with ongoing infectious insult in sepsis. Various other cytokine/chemokines, cell markers, receptor markers, vasodilation markers, vascular endothelial damage markers, coagulation markers, organ dysfunction markers, apoptosis markers, selenium, saliva biomarkers, and emerging biomarkers are also under evaluation. CRP > 10 mg/dL reflects acute infection. Procalcitonin above 0.25 ng/mL is the cut off for initiation of antimicrobial therapy, between 0.5-2 ng/mL reflects sepsis, and >2 ng/ml stratifies high risk of septic shock.
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CONCLUSION
Polymicrobial sepsis can rapidly deteriorate a patient and mandate aggressive fluid, inotrope, ventilation, and antimicrobial therapy, notwithstanding challenges in diagnosis, prognosis and optimal management which demand intuitive mental mobility to discern role of infectious versus noninfectious insults, bacterial versus non-bacterial causation, antimicrobial initiation, escalation and de-escalation, diagnostic and prognostic correlates, pathophysiological compromise, drug toxicity and ongoing risk stratification.
